Inhibrx Biosciences, Inc. INBX Increase Decrease In Due From Related Parties
Increase Decrease In Due From Related Parties at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDueFromRelatedParties.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s increase decrease in due from related parties.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s increase decrease in due from related parties?
- Inhibrx Biosciences, Inc. (INBX) reported increase decrease in due from related parties of $0 in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s increase decrease in due from related parties changed year-over-year?
- Inhibrx Biosciences, Inc.'s increase decrease in due from related parties increased by 100.0% year-over-year, from -$23K to $0.
- What does increase decrease in due from related parties mean?
- This tracks the net change in outstanding balances owed to the company by affiliated entities, subsidiaries, or key management personnel. An increase indicates cash tied up in receivables from related parties, potentially signaling liquidity constraints or complex intercompany financing arrangements. Investors monitor this to assess the quality of earnings and the potential for related-party transaction risks.